{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T21:39:52Z","timestamp":1782337192621,"version":"3.54.5"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1097\/md.0b013e3181f27e8f","type":"journal-article","created":{"date-parts":[[2010,9,8]],"date-time":"2010-09-08T11:01:57Z","timestamp":1283943717000},"page":"300-307","source":"Crossref","is-referenced-by-count":51,"title":["Outcomes in Biopsy-Proven Lupus Nephritis"],"prefix":"10.1097","volume":"89","author":[{"given":"Antoni","family":"Sis\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ramos-Casals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Bov\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Brito-Zer\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma","family":"Nardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Testi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Perez-de-Lis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e1ndido","family":"D\u00edaz-Lagares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Darnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Sent\u00eds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Coca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210309","first-page":"1265","article-title":"Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality.","volume":"22","author":"Abu-Shakra","year":"1995","journal-title":"J Rheumatol"},{"key":"R2-4-20210309","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/rheumatology\/kel039","article-title":"An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period.","volume":"45","author":"Adler","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R3-4-20210309","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1093\/rheumatology\/keg291","article-title":"Survival and mortality rates of systemic lupus erythematosus patients in northwest Greece. Study of a 21-year incidence cohort.","volume":"42","author":"Alamanos","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"R4-4-20210309","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/ard.2006.068676","article-title":"Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L).","volume":"66","author":"Alarcon","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R5-4-20210309","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0002-9343(87)90645-0","article-title":"Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization.","volume":"83","author":"Appel","year":"1987","journal-title":"Am J Med"},{"key":"R6-4-20210309","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1681\/ASN.2007121272","article-title":"Successful treatment of class V+IV lupus nephritis with multitarget therapy.","volume":"19","author":"Bao","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R7-4-20210309","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1191\/0961203306lu2271oa","article-title":"Sustained remission of lupus nephritis.","volume":"15","author":"Barber","year":"2006","journal-title":"Lupus"},{"key":"R8-4-20210309","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/ndt\/gfg345","article-title":"Prognosis in proliferative lupus nephritis: the role of socio-economic status and race\/ethnicity.","volume":"18","author":"Barr","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R9-4-20210309","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/rheumatology\/kel347","article-title":"Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors predictive of new or worsening proteinuria.","volume":"46","author":"Bastian","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"R10-4-20210309","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.revmed.2004.09.003","article-title":"Nephropathie lupique: a propos de 211 cas.","volume":"26","author":"Beji","year":"2005","journal-title":"Rev Med Interne"},{"key":"R11-4-20210309","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/ard.2007.083030","article-title":"EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints.","volume":"68","author":"Bertsias","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R13-4-20210309","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/qjmed\/92.4.211","article-title":"The very long-term prognosis and complications of lupus nephritis and its treatment.","volume":"92","author":"Bono","year":"1999","journal-title":"QJM"},{"key":"R14-4-20210309","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0140-6736(92)92292-N","article-title":"Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.","volume":"340","author":"Boumpas","year":"1992","journal-title":"Lancet"},{"key":"R15-4-20210309","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1177\/0961203307080225","article-title":"Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multi-ethnic New Zealand cohort.","volume":"16","author":"Burling","year":"2007","journal-title":"Lupus"},{"key":"R16-4-20210309","first-page":"1","article-title":"Systemic lupus erythematosus with nephritis: a long-term study.","volume":"48","author":"Cameron","year":"1979","journal-title":"Q J Med"},{"key":"R17-4-20210309","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.autrev.2006.02.015","article-title":"European Working Party on Systemic Lupus Erythematosus. European Working Party on Systemic Lupus Erythematosus: a 15-year report.","volume":"5","author":"Cervera","year":"2006","journal-title":"Autoimmun Rev"},{"key":"R19-4-20210309","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1681\/ASN.2004080686","article-title":"Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.","volume":"16","author":"Chan","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R20-4-20210309","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1038\/sj.ki.5000243","article-title":"Outcomes in African Americans and Hispanics with lupus nephritis.","volume":"69","author":"Contreras","year":"2006","journal-title":"Kidney Int"},{"key":"R21-4-20210309","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMoa031855","article-title":"Sequential therapies for proliferative lupus nephritis.","volume":"350","author":"Contreras","year":"2004","journal-title":"N Engl J Med"},{"key":"R22-4-20210309","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1056\/NEJM198301273080403","article-title":"The long-term clinical course of systemic lupus erythematosus in end-stage renal disease.","volume":"308","author":"Coplon","year":"1983","journal-title":"N Engl J Med"},{"key":"R23-4-20210309","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1191\/0961203303lu340oa","article-title":"Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone.","volume":"12","author":"Cortes-Hernandez","year":"2003","journal-title":"Lupus"},{"issue":"Suppl 2","key":"R24-4-20210309","first-page":"106","article-title":"Lupus nephritis in Northern Ireland: implications for nephritis screening.","volume":"41","author":"Courtney","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"R25-4-20210309","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1191\/0961203303lu444oa","article-title":"Relapses of lupus nephritis: incidence, risk factors, serology and impact on outcome.","volume":"12","author":"El Hachmi","year":"2003","journal-title":"Lupus"},{"key":"R26-4-20210309","first-page":"1563","article-title":"Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure.","volume":"33","author":"Faurschou","year":"2006","journal-title":"J Rheumatol"},{"key":"R27-4-20210309","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1053\/S0049-0172(03)00133-1","article-title":"Clusters of clinical and immunologic features in systemic lupus erythematosus: analysis of 600 patients from a single center.","volume":"33","author":"Font","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"R28-4-20210309","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/qjmed\/94.1.19","article-title":"Cardiovascular risk factors and the long-term outcome of lupus nephritis.","volume":"94","author":"Font","year":"2001","journal-title":"QJM"},{"key":"R29-4-20210309","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa043731","article-title":"Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.","volume":"353","author":"Ginzler","year":"2005","journal-title":"N Engl J Med"},{"key":"R30-4-20210309","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/sj.ki.5001630","article-title":"Hagen EC, van den Wall Bake AW, de Glas-Vos JW, Bijl M, Assmann KJ, Bruijn JA, Weening JJ, van Houwelingen HC, Derksen RH, Berden JH; Dutch Working Party on Systemic Lupus Erythematosus. Azathioprine\/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.","volume":"70","author":"Grootscholten","year":"2006","journal-title":"Kidney Int"},{"key":"R31-4-20210309","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R32-4-20210309","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/art.10461","article-title":"Immunosuppresive therapy in lupus nephritis. The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.","volume":"46","author":"Houssiau","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R33-4-20210309","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1002\/art.20666","article-title":"Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from the long-term follow-up of the Euro-Lupus Nephritis Trial.","volume":"50","author":"Houssiau","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R34-4-20210309","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00005792-199905000-00002","article-title":"Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center.","volume":"78","author":"Huong","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"R35-4-20210309","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/art.10142","article-title":"Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term follow-up of a cohort of 145 patients participating in randomized controlled studies.","volume":"46","author":"Illei","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R36-4-20210309","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1191\/0961203306lu2313oa","article-title":"Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis.","volume":"15","author":"Kasitanon","year":"2006","journal-title":"Lupus"},{"key":"R37-4-20210309","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0272-6386(00)70262-9","article-title":"Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group.","volume":"35","author":"Korbet","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"R38-4-20210309","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1681\/ASN.2006090992","article-title":"Severe lupus nephritis: racial differences in presentation and outcome.","volume":"18","author":"Korbet","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R39-4-20210309","doi-asserted-by":"crossref","first-page":"114","DOI":"10.7326\/0003-4819-116-2-114","article-title":"Progression and remission of renal disease in the Lupus Nephritis Collaborative Study: results of treatment with prednisone and short-term oral cyclophosphamide.","volume":"116","author":"Levey","year":"1992","journal-title":"Ann Intern Med"},{"issue":"Suppl 2","key":"R40-4-20210309","first-page":"107","article-title":"An analysis of end stage renal failure in SLE patients in the UK: experience of a combined cohort in London and Birmingham.","volume":"41","author":"Li","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"R41-4-20210309","first-page":"701","article-title":"Clinical predictors of recovery and complications in the management of recent-onset renal failure in lupus nephritis: a Chinese experience.","volume":"31","author":"Liang","year":"2004","journal-title":"J Rheumatol"},{"key":"R42-4-20210309","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/art.1780370417","article-title":"Kidney biopsy in systemic lupus erythematosus.","volume":"37","author":"McLaughlin","year":"1994","journal-title":"Arthritis Rheum"},{"key":"R44-4-20210309","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1046\/j.1523-1755.2002.00280.x","article-title":"Renal flares in 91 SLE patients with diffuse proliferative glomerulonephritis.","volume":"61","author":"Mosca","year":"2002","journal-title":"Kidney Int"},{"key":"R45-4-20210309","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1046\/j.1523-1755.2001.00730.x","article-title":"Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis.","volume":"59","author":"Najafi","year":"2001","journal-title":"Kidney Int"},{"key":"R46-4-20210309","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0049-0172(95)80017-4","article-title":"Lupus in the 1980s: III. Influence of clinical variables, biopsy, and treatment on the outcome in 150 patients with lupus nephritis seen at a single center.","volume":"25","author":"Neumann","year":"1995","journal-title":"Semin Arthritis Rheum"},{"key":"R47-4-20210309","first-page":"9","article-title":"The effect of race on incidence and clinical course in systemic lupus erythematosus: The Hopkins Lupus Cohort.","volume":"53","author":"Petri","year":"1998","journal-title":"J Am Med Womens Assoc"},{"key":"R48-4-20210309","first-page":"150","article-title":"The Canadian Hydroxychloroquine Study Group.","volume":"324","year":"1991","journal-title":"N Engl J Med"},{"key":"R49-4-20210309","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3899\/jrheum.080335","article-title":"Current therapies for lupus nephritis in an ethnically heterogeneous cohort.","volume":"36","author":"Rivera","year":"2009","journal-title":"J Rheumatol"},{"key":"R50-4-20210309","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/0961203306071872","article-title":"Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus.","volume":"15","author":"Ruiz-Irastorza","year":"2006","journal-title":"Lupus"},{"key":"R51-4-20210309","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.2008.101766","article-title":"Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review.","volume":"69","author":"Ruiz-Irastorza","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R52-4-20210309","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/0961203307086503","article-title":"Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival.","volume":"17","author":"Siso","year":"2008","journal-title":"Lupus"},{"key":"R53-4-20210309","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/ard.2008.088740","article-title":"Delayed lupus nephritis.","volume":"67","author":"Varela","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R54-4-20210309","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0002-9343(82)90812-9","article-title":"Lupus nephritis. Experience with 230 patients in a private practice from 1950 to 1980.","volume":"72","author":"Wallace","year":"1982","journal-title":"Am J Med"},{"key":"R55-4-20210309","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1046\/j.1523-1755.2000.00065.x","article-title":"Outcomes of renal transplantation among patients with end-stage renal disease caused by lupus nephritis.","volume":"57","author":"Ward","year":"2000","journal-title":"Kidney Int"},{"key":"R56-4-20210309","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited.","volume":"15","author":"Weening","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R57-4-20210309","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00000441-200406000-00005","article-title":"The clinical and epidemiologic features in 140 patients with lupus nephritis in a predominantly black population from one center in Kingston, Jamaica.","volume":"327","author":"Williams","year":"2004","journal-title":"Am J Med Sci"},{"key":"R58-4-20210309","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/ard.2002.003574","article-title":"EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.","volume":"63","author":"Yee","year":"2004","journal-title":"Ann Rheum Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0b013e3181f27e8f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:33:13Z","timestamp":1620963193000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201009000-00004"}},"subtitle":["Evaluation of 190 White Patients From a Single Center"],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0b013e3181f27e8f","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}